205 related articles for article (PubMed ID: 33386326)
1. Principles of Harm Reduction for Young People Who Use Drugs.
Kimmel SD; Gaeta JM; Hadland SE; Hallett E; Marshall BDL
Pediatrics; 2021 Jan; 147(Suppl 2):S240-S248. PubMed ID: 33386326
[TBL] [Abstract][Full Text] [Related]
2. Evidence-Based Treatment of Young Adults With Substance Use Disorders.
Hadland SE; Yule AM; Levy SJ; Hallett E; Silverstein M; Bagley SM
Pediatrics; 2021 Jan; 147(Suppl 2):S204-S214. PubMed ID: 33386323
[TBL] [Abstract][Full Text] [Related]
3. Principles of Care for Young Adults With Substance Use Disorders.
Silverstein M; Hadland SE; Hallett E; Botticelli M
Pediatrics; 2021 Jan; 147(Suppl 2):S195-S203. PubMed ID: 33386322
[TBL] [Abstract][Full Text] [Related]
4. Harm Reduction for Adolescents and Young Adults During the COVID-19 Pandemic: A Case Study of Community Care in Reach.
Noyes E; Yeo E; Yerton M; Plakas I; Keyes S; Obando A; Gaeta JM; Taveras EM; Chatterjee A
Public Health Rep; 2021 May; 136(3):301-308. PubMed ID: 33673755
[TBL] [Abstract][Full Text] [Related]
5. Support Services for Young Adults With Substance Use Disorders.
Xuan Z; Choi J; Lobrutto L; Cunningham T; Castedo de Martell S; Cance J; Silverstein M; Yule AM; Botticelli M; Holleran Steiker L
Pediatrics; 2021 Jan; 147(Suppl 2):S220-S228. PubMed ID: 33386325
[TBL] [Abstract][Full Text] [Related]
6. The Justice System and Young Adults With Substance Use Disorders.
Siringil Perker S; Chester LEH
Pediatrics; 2021 Jan; 147(Suppl 2):S249-S258. PubMed ID: 33386327
[TBL] [Abstract][Full Text] [Related]
7. Addressing adolescent substance use with a public health prevention framework: the case for harm reduction.
Winer JM; Yule AM; Hadland SE; Bagley SM
Ann Med; 2022 Dec; 54(1):2123-2136. PubMed ID: 35900132
[TBL] [Abstract][Full Text] [Related]
8. Engaging the Family in the Care of Young Adults With Substance Use Disorders.
Bagley SM; Ventura AS; Lasser KE; Muench F
Pediatrics; 2021 Jan; 147(Suppl 2):S215-S219. PubMed ID: 33386324
[TBL] [Abstract][Full Text] [Related]
9. Harm reduction for young people who use prescription opioids extra-medically: Obstacles and opportunities.
Marshall BD; Green TC; Yedinak JL; Hadland SE
Int J Drug Policy; 2016 May; 31():25-31. PubMed ID: 26919826
[TBL] [Abstract][Full Text] [Related]
10. Harm reduction services as a point-of-entry to and source of end-of-life care and support for homeless and marginally housed persons who use alcohol and/or illicit drugs: a qualitative analysis.
McNeil R; Guirguis-Younger M; Dilley LB; Aubry TD; Turnbull J; Hwang SW
BMC Public Health; 2012 May; 12():312. PubMed ID: 22545586
[TBL] [Abstract][Full Text] [Related]
11. Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus study.
Wiessing L; Ferri M; Běláčková V; Carrieri P; Friedman SR; Folch C; Dolan K; Galvin B; Vickerman P; Lazarus JV; Mravčík V; Kretzschmar M; Sypsa V; Sarasa-Renedo A; Uusküla A; Paraskevis D; Mendão L; Rossi D; van Gelder N; Mitcheson L; Paoli L; Gomez CD; Milhet M; Dascalu N; Knight J; Hay G; Kalamara E; Simon R; ; Comiskey C; Rossi C; Griffiths P
Harm Reduct J; 2017 Apr; 14(1):19. PubMed ID: 28431584
[TBL] [Abstract][Full Text] [Related]
12. Results of a participatory needs assessment demonstrate an opportunity to involve people who use alcohol in drug user activism and harm reduction.
Crabtree A; Latham N; Bird L; Buxton J
Harm Reduct J; 2016 Dec; 13(1):37. PubMed ID: 27938376
[TBL] [Abstract][Full Text] [Related]
13. Intersecting substance use treatment and harm reduction services: exploring the characteristics and service needs of a community-based sample of people who use drugs.
Krawczyk N; Allen ST; Schneider KE; Solomon K; Shah H; Morris M; Harris SJ; Sherman SG; Saloner B
Harm Reduct J; 2022 Aug; 19(1):95. PubMed ID: 36002850
[TBL] [Abstract][Full Text] [Related]
14. Harm reduction via online platforms for people who use drugs in Russia: a qualitative analysis of web outreach work.
Davitadze A; Meylakhs P; Lakhov A; King EJ
Harm Reduct J; 2020 Dec; 17(1):98. PubMed ID: 33298081
[TBL] [Abstract][Full Text] [Related]
15. Substance use and sleep health in young adults: Implications for integrated treatment and harm reduction.
Goodhines PA; Rathod K
Sleep Med Rev; 2023 Aug; 70():101811. PubMed ID: 37423096
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 and the opportunity for gender-responsive virtual and remote substance use treatment and harm reduction services.
Perri M; Schmidt RA; Guta A; Kaminski N; Rudzinski K; Strike C
Int J Drug Policy; 2022 Oct; 108():103815. PubMed ID: 35969920
[TBL] [Abstract][Full Text] [Related]
17. Harm reduction in practice - The Community Oriented Substance Use Programme in Tshwane.
Scheibe A; Shelly S; Hugo J; Mohale M; Lalla S; Renkin W; Gloeck N; Khambule S; Kroukamp L; Bhoora U; Marcus TS
Afr J Prim Health Care Fam Med; 2020 May; 12(1):e1-e6. PubMed ID: 32501031
[TBL] [Abstract][Full Text] [Related]
18. "You know, we can change the services to suit the circumstances of what is happening in the world": a rapid case study of the COVID-19 response across city centre homelessness and health services in Edinburgh, Scotland.
Parkes T; Carver H; Masterton W; Falzon D; Dumbrell J; Grant S; Wilson I
Harm Reduct J; 2021 Jun; 18(1):64. PubMed ID: 34118942
[TBL] [Abstract][Full Text] [Related]
19. Principles of Care for Young Adults With Co-Occurring Psychiatric and Substance Use Disorders.
Spencer AE; Valentine SE; Sikov J; Yule AM; Hsu H; Hallett E; Xuan Z; Silverstein M; Fortuna L
Pediatrics; 2021 Jan; 147(Suppl 2):229-239. PubMed ID: 33386320
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
